Take Solutions Q2 FY27: PAT ₹1.06 & Rev ₹30.37

Metric	Value
Revenue	₹30.37
Net Profit (PAT)	₹1.06

📢 Key Event
TAKE Limited reports Q1 FY27 revenue of ₹30.37 Cr and net profit of ₹1.06 Cr

🔄 What Changed
Revenue of ₹30.37 Cr, net profit of ₹1.06 Cr, finance costs of ₹0.07 Lakhs

🔮 What's Next
Strategic entry into longevity and anti-ageing market with high-margin recurring revenue model

💡 Investor Takeaway
The company has returned to profitability with minimal finance costs, signaling operational stabilization and a shift toward high-growth wellness markets.

TAKE Limited reported consolidated revenue of ₹30.37 Cr and net profit of ₹1.06 Cr for Q1 FY27, reversing a prior-year net loss while finance costs dropped 99.6% to ₹0.07 Lakhs, reflecting a lean balance sheet and operational turnaround.

📄 View Original Announcement (PDF)

📊 Stock Analysis — TAKE ✨ Ask AI About This

About Take Solutions Limited (TAKE)

Healthcare · Healthcare · Listed on NSE

Market Cap: ₹217.46 Cr P/E: 17.1 ROE: 62.5% ROCE: 30.4%

View full TAKE stock details →

📡 Get AI alerts when TAKE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track TAKE — Free

💡 Ask AI about this filing

"What is the projected revenue contribution from the longevity segment?" "How will recurring revenue be measured and scaled?" "What regulatory milestones are expected in the next 12 months?"

Ask AI Free →

📊 More TAKE filings

See all TAKE filings →

🔥 Also filed on 11 August 2026

ULTRACEMCO UltraTech Cement Limited Announcement SUDEEPPHRM Sudeep Pharma Limited Financial Results SUTLEJTEX Sutlej Textiles and Industries Limited Financial Results RBZJEWEL RBZ Jewellers Limited Financial Results TATVA Tatva Chintan Pharma Chem Limited Corporate Action AETHER Aether Industries Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when TAKE files new disclosures

Track TAKE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track TAKE — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd